Evidence map›Paper›PMID 36246997›Full record

ArticleContemporary clinical trials communications2022

Protocol for the AKT-MP trial: Access to Kidney Transplantation in Minority Populations.

Jamie M Loor, Nila S Judd, Claudia M Rice, Diana D Perea, Emilee Croswell, Pooja P Singh, Mark Unruh, Yiliang Zhu, Ashwini R Sehgal, Sarah L Goff and 2 more

Open access · goldAbstract read
In one paragraph

Article in Contemporary clinical trials communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Jamie M LoorCenter for Healthcare Equity in Kidney Disease (CHEK-D), University of New Mexico Health Science Center, United States.
Nila S JuddCenter for Healthcare Equity in Kidney Disease (CHEK-D), University of New Mexico Health Science Center, United States.
Claudia M RiceCenter for Healthcare Equity in Kidney Disease (CHEK-D), University of New Mexico Health Science Center, United States.
Diana D PereaCenter for Healthcare Equity in Kidney Disease (CHEK-D), University of New Mexico Health Science Center, United States.
Emilee CroswellDepartment of Psychiatry, University of Pittsburgh, United States.
Pooja P SinghDepartment of Internal Medicine, University of New Mexico, School of Medicine, United States.
Mark UnruhDepartment of Internal Medicine, University of New Mexico, School of Medicine, United States.
Yiliang ZhuDepartment of Internal Medicine, University of New Mexico, School of Medicine, United States.
Ashwini R SehgalDepartment of Medicine, Case Western Reserve University, United States.
Sarah L GoffDepartment of Health Policy and Management, University of Massachusetts, Amherst, United States.
Cindy L BryceDepartment of Health Policy and Management, University of Pittsburgh, School of Public Health, United States.
Larissa MyaskovskyCenter for Healthcare Equity in Kidney Disease (CHEK-D), University of New Mexico Health Science Center, United States.
University of New Mexico · USUniversity of Pittsburgh · USCase Western Reserve University · USUniversity of Massachusetts Amherst · US

Funding

Access to Kidney Transplantation in Minority Populations (AKT-MP)R01MD013752 · NIMHD · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI MYASKOVSKY, LARISSA · 2020 to 2025
$2.9M
NIMHD NIH HHS R01 MD013752
6 · The paper itself

Abstract

Background: Kidney transplant (KT) is the optimal treatment for kidney failure (KF), and although completion of KT evaluation is an essential step in gaining access to transplantation, the process is lengthy, time consuming, and burdensome. Furthermore, despite similar referral rates to non-Hispanic Whites, both Hispanic/Latinos and American Indians are less likely to be wait-listed or to undergo KT. Methods: The Access to Kidney Transplantation in Minority Populations (AKT-MP) Trial compares two patient-centered methods to facilitate KT evaluation: kidney transplant fast track (KTFT), a streamlined KT evaluation process; and peer navigators (PN), a peer-assisted evaluation program that incorporates motivational interviewing. This pragmatic randomized trial will use a comparative effectiveness approach to assess whether KTFT or PN can help patients overcome barriers to transplant listing. We will randomly assign patients to the two conditions. We will track participants' medical records and conduct surveys prior to their initial evaluation clinic visit and again after they complete or discontinue evaluation. Conclusion: Our aims are to (1) compare KTFT and PN to assess improvements in kidney transplant (KT) related outcomes and cost effectiveness; (2) examine how each approach effects changes in cultural/contextual factors, KT concerns, KT knowledge, and KT ambivalence; and (3) develop a framework for widespread implementation of either approach. The results of this trial will provide key information for facilitating the evaluation process, improving patient care, and decreasing disparities in KT.

Indexed as

AI, American IndianAKT-MP, Access to Kidney Transplantation in Minority PopulationsAmerican IndianHealthcare equityHispanic/latinoHL, Hispanic or LatinoKAS, Kidney Allocation SystemKF, kidney failureKidney transplantKTFT, kidney transplant fast trackKT, kidney transplantPeer navigationPN, peer navigator

Identifiers

PMID36246997
PMCPMC9562954
OpenAlexW4301398522

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.